18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism
NCT04205604
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Congenital Hyperinsulinism
Interventions
DRUG:
18F-Fluoro Dopa Imaging
Sponsor
Miguel Pampaloni